UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström's macroglobulinemia and related lymphoid neoplasms

Blood, 2013-03, Vol.121 (13), p.2522-2528

2013

Volltextzugriff (PDF)

HCV infection and non-Hodgkin lymphomas: an evolving story

Clinical and experimental medicine, 2020-08, Vol.20 (3), p.321-328

2020

Volltextzugriff (PDF)

Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)

British journal of haematology, 2019-05, Vol.185 (4), p.713-717

2019

Volltextzugriff (PDF)

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

Blood, 2012-01, Vol.119 (1), p.188-191

2012

Volltextzugriff (PDF)

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

Haematologica (Roma), 2015-02, Vol.100 (2), p.246

2015

Volltextzugriff (PDF)

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

Haematologica (Roma), 2014-03, Vol.99 (3), p.489

2014

Volltextzugriff (PDF)

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

Haematologica (Roma), 2010-10, Vol.95 (10), p.1792-1796

2010

Volltextzugriff (PDF)

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy

Clinical & developmental immunology, 2012-01, Vol.2012, p.638185-10

2012

Volltextzugriff (PDF)

Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study

Microorganisms (Basel), 2023-05, Vol.11 (5), p.1305

2023

Volltextzugriff (PDF)

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy

Journal of clinical medicine, 2022-12, Vol.11 (24), p.7452

2022

Volltextzugriff (PDF)

Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients

British journal of haematology, 2010-05, Vol.149 (3), p.455-457

2010

Volltextzugriff (PDF)

Impact of treatment‐related liver toxicity on the outcome of HCV‐positive non‐Hodgkin's lymphomas

American journal of hematology, 2010-01, Vol.85 (1), p.46-50

2010

Volltextzugriff (PDF)

Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

HemaSphere, 2020-02, Vol.4 (1), p.e302-n/a

2020

Volltextzugriff (PDF)

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

TheScientificWorld, 2012-01, Vol.2012, p.107892-5

2012

Volltextzugriff (PDF)

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry

European journal of haematology, 2010-11, Vol.85 (5), p.405-415

2010

Volltextzugriff (PDF)

Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma

Expert opinion on pharmacotherapy, 2021-09, Vol.22 (13), p.1643-1649

2021

Volltextzugriff (PDF)

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

Human pathology, 2009-11, Vol.40 (11), p.1628-1637

2009

Volltextzugriff (PDF)

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Blood, 2020-01, Vol.135 (4), p.293-296

2020

Volltextzugriff (PDF)

Antiviral therapies for managing viral hepatitis in lymphoma patients

Expert opinion on pharmacotherapy, 2017-03, Vol.18 (4), p.363-376

2017

Volltextzugriff (PDF)

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4060-4070

2022

Volltextzugriff (PDF)

Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies

British journal of haematology, 2015-01, Vol.168 (2), p.301-302

2015

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(86)

Sprache

Englisch
(86)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström's macroglobulinemia and related lymphoid neoplasms

HCV infection and non-Hodgkin lymphomas: an evolving story

Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy

Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy

Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients

Impact of treatment‐related liver toxicity on the outcome of HCV‐positive non‐Hodgkin's lymphomas

Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry

MYC Rearranged Aggressive B‐Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)

Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Antiviral therapies for managing viral hepatitis in lymphoma patients

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi

Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies

Suchergebnisse filtern